Title Participants "Default matrimonial property regimes and the principles of European family law - a European-South African comparison (part 2)" "Walter Pintens" "Distinguishing between use and abuse of EU free movement law : evaluating use of the 'Europe-route' for family reunification to overcome reverse discrimination" "Hester Kroeze" "Distinguishing between use and abuse of EU free movement law : evaluating use of the 'Europe-route' for family reunification to overcome reverse discrimination" "Hester Kroeze" "Reworked and updated version of the paper 'Distinguishing between Use and Abuse of EU Free Movement Law: Evaluating Use of the ""Europe Route"" for Family Reunification to Overcome Reverse Discrimination' in European Papers." "A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010" "P. Heyman, C Ceianu, I Christova, N Tordo, M Beersma, M João Alves, A Lundkvist, M Hukic, A Papa, A Tenorio, H Zelená, S Essbauer, I. Visontai, I Golovljova, J Connell, L Nicoletti, Marjan Van Esbroeck, S Gjeruldsen Dudman, S Aberle, T Avsic-Zupanc, G Korukluoglu, A Nowakowska, B Klempa, R Ulrich, S Bino, O Engler, M Opp, A Vaheri" "West Nile virus infection in Belgian traveler returning from Greece [letter]" "Lieselotte Cnops, A Papa, F. Lagra, P. Weyers, Kathleen Meersman, N. Patsouros, Marjan Van Esbroeck" "First survey on canine leishmaniasis in a non classical area of the disease in Spain (Lleida, Catalonia) based on a veterinary questionnaire and a cross-sectional study" "C. Ballart, M.M. Alcover, Albert Picado De Puig, J. Nieto, S. Castillejo, M. Portús, M. Gállego" "The Spanish distribution of canine leishmaniasis (CanL) is heterogeneous and very few data are available for the north of the country, including the province of Lleida (Catalonia, Spain). This work describes the results obtained from a questionnaire sent to veterinarians throughout the province of Lleida. The majority of veterinarians (25/32, 78.1%) believed CanL cases were increasing and that the dogs had been infected locally (30/32, 93.8%). Also, a cross-sectional study was performed on the seroprevalence of CanL in kennel dogs, with and without compatible clinical signs, in the county of Pallars Sobira (Pyrenees of Lleida), where an autochthonous case of CanL had been previously detected. Four serological tests were used (IFAT, ELISA, Western blot, ICF) and dogs that tested positive with at least two immunological methods were considered seropositive and probably infected. 33.1% (48/145) of the dogs were seropositive. The results of a mixed logistic regression model showed that the risk of seropositivity increased with age (OR=1.35, p-value=0.002), among dogs living in the southern part of Pallars Sobira (OR=6.20, p-value=0.025) and among dogs whose owners considered their animals to be at risk of leishmaniasis infection (OR=1.26, p-value=0.024) and who were unaware of anti-sand fly preventive methods (OR=11.6, p-value=0.009). The risk decreased when dogs lived in an urban-periurban habitat (OR=0.17, p-value=0.002). The information gathered in the veterinary questionnaires helped us to define the knowledge, perception and awareness of the disease in a naive region, supporting the hypothesis of an existing CanL focus in Pallars Sobira, which was confirmed by the seroepidemiological survey. The seroprevalence study carried out on kennel dogs of local origin proved useful for detecting an autochthonous focus of leishmaniasis through the analysis of a small number of animals." "Patients' satisfaction with sexual and reproductive health services delivered in HIV clinics across European regions" "Tom Platteau, M.C. Müller, S. Nideröst, P. Csepe, N. Dedes, Ludwig Apers, W. Schrooten, Christiana Nöstlinger" "How do primary health care teams learn to integrate intimate partner violence (IPV) management? A realist evaluation protocol" "I. Goicolea, C. Vives-Cases, M. San Sebastian, Bruno Marchal, Guy Kegels, A.K. Hurtig" "BACKGROUND: Despite the existence of ample literature dealing, on the one hand, with the integration of innovations within health systems and team learning, and, on the other hand, with different aspects of the detection and management of intimate partner violence (IPV) within healthcare facilities, research that explores how health innovations that go beyond biomedical issues-such as IPV management-get integrated into health systems, and that focuses on healthcare teams' learning processes is, to the best of our knowledge, very scarce if not absent. This realist evaluation protocol aims to ascertain: why, how, and under what circumstances primary healthcare teams engage (if at all) in a learning process to integrate IPV management in their practices; and why, how, and under what circumstances team learning processes lead to the development of organizational culture and values regarding IPV management, and the delivery of IPV management services. METHODS: This study will be conducted in Spain using a multiple-case study design. Data will be collected from selected cases (primary healthcare teams) through different methods: individual and group interviews, routinely collected statistical data, documentary review, and observation. Cases will be purposively selected in order to enable testing the initial middle-range theory (MRT). After in-depth exploration of a limited number of cases, additional cases will be chosen for their ability to contribute to refining the emerging MRT to explain how primary healthcare learn to integrate intimate partner violence management. DISCUSSION: Evaluations of health sector responses to IPV are scarce, and even fewer focus on why, how, and when the healthcare services integrate IPV management. There is a consensus that healthcare professionals and healthcare teams play a key role in this integration, and that training is important in order to realize changes. However, little is known about team learning of IPV management, both in terms of how to trigger such learning and how team learning is connected with changes in organizational culture and values, and in service delivery. This realist evaluation protocol aims to contribute to this knowledge by conducting this project in a country, Spain, where great endeavours have been made towards the integration of IPV management within the health system." "Comparison of bovine cysticercosis prevalence detected by antigen ELISA and visual inspection in the North East of Spain" "A. Allepuz, Sarah Gabriël, Pierre Dorny, S. Napp, Famke Jansen, M.J. Vilar, L. Vives, L. Picart, A. Ortuño, J. Gutiérrez, J. Casal" "A cross-sectional serological study on cattle less than 2years old, using an antigen ELISA for the detection of bovine cysticercosis was carried out between November 2009 and February 2010 in 10 slaughterhouses from the Catalonia region (North-Eastern Spain). Circulating antigen was detected in 23 of 2073 animals, i.e. a sero-prevalence of 1.11% (CI95%: 0.76-1.75%). The determined sero-prevalence was about 50 times higher than the prevalence obtained by visual inspection within the same period: 19 positive animals of 90,891 slaughtered animals (0.02%) in the same slaughterhouses. None of the animals with positive result in the Ag-ELISA was detected by meat inspection." "Efficacy study of novel diamidine compounds in a Trypanosoma evansi goat model" "K. Gillingwater, C. Gutierrez, A Bridges, H Wu, Stijn Deborggraeve, Rosine Ali Ekangu, A Kumar, M Ismail, D Boykin, R. Brun" "Three diamidines (DB 75, DB 867 and DB 1192) were selected and their ability to cure T. evansi experimentally infected goats was investigated. A toxicity assessment and pharmacokinetic analysis of these compounds were additionally carried out. Goats demonstrated no signs of acute toxicity, when treated with four doses of 1 mg/kg/day (total dose 4 mg/kg). Complete curative efficacy of experimentally infected goats was seen in the positive control group treated with diminazene at 5 mg/kg and in the DB 75 and DB 867 groups treated at 2.5 mg/kg. Drug treatment was administered once every second day for a total of seven days. Complete cure was also seen in the group of goats treated with DB 75 at 1.25 mg/kg. DB 1192 was incapable of curing goats at either four-times 2.5 mg/kg or 1.25 mg/kg. Pharmacokinetic analysis clearly demonstrated that the treatment failures of DB 1192 were due to sub-therapeutic compound levels in goat plasma, whilst compound levels for DB 75 and DB 867 remained well within the therapeutic window. In conclusion, two diamidine compounds (DB 75 and DB 867) presented comparable efficacy at lower doses than the standard drug diminazene and could be considered as potential clinical candidates against T. evansi infection."